Official Code of Georgia Annotated

Title 31. HEALTH · Chapter 52. TERMINALLY ILL PATIENT’S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES · Article 2. INDIVIDUALIZED INVESTIGATIONAL TREATMENT

31-52-21. Physician documentation of eligibility.

Active

Current through: Including Acts of the 2025 Session of the General Assembly of Georgia.

In order for a person to be considered an eligible patient to access an individualized investigational treatment pursuant to this article, a physician must document in writing that the person:
(1)
Has a life-threatening or severely debilitating illness;#
(2)
Has, in consultation with the physician, considered all other treatment options currently approved by the United States Food and Drug Administration;#
(3)
Has been given a recommendation by the physician for an individualized investigational treatment based on an analysis of such patient’s genomic sequence, human chromosomes, deoxyribonucleic acid, ribonucleic acid, genes, gene products such as enzymes and other types of proteins, or metabolites; and#
(4)
Has given written informed consent for the use of the individualized investigational treatment.#

The notes below are printed with the section but are not enacted law (O.C.G.A. § 1-1-1(c)). They are shown apart from the text.

History

Code 1981, § 31-52-21, enacted by Ga. L. 2025, p. 455, § 5/SB 72, effective July 1, 2025.

Read the official page (the state's PDF, opened at the page this text was read from).

Current through: Including Acts of the 2025 Session of the General Assembly of Georgia.

Text read from t31-(v23)-2025-pdf.pdf, Volume V23, 2025 edition, page 1093; merge action: bound only; file SHA-256 ba5a57f85d04.

Ask about this section

The answer is drawn from this section and, when they fit, the other sections of its chapter. It quotes the text and names the section for each claim. Not legal advice.